Stocks in play: Medicenna Therapeutics Corp.
Announced today that Dr. Fahar Merchant, President and CEO of Medicenna, will present and participate in one-on-one meetings at the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8-10, at the Lotte New York Palace Hotel in New York City. Medicenna Therapeutics Corp. shares T.MDNA are trading up $0.03 at $1.09.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.